Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo

Kidney International

Volumn 52, Issue 2, 1997, Pages 404-413

  Shankland, Stuart J ^a   Floege, Jürgen ^b   Thomas, Susan E ^b   Nangaku, Masaomi ^b   Hugo, Christian ^b   Pippin, Jeffrey ^b   Henne, Kevin ^b   Hockenberry, David M ^b   Johnson, Richard J ^b   Couser, William G ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Apoptosis; Cell cycle; Cyclin; Glomerular epithelial cell; Injury; Membranous nephropathy; Podocyte

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GLOMERULOSCLEROSIS; GLOMERULUS EPITHELIUM; HEYMANN NEPHRITIS; MALE; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; RAT;

EID: 8544282400     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.347     Document Type: Article

References (48)

1. MUNDEL P, KRIZ W: Structure and function of podocytes: An update. Acta Embryol 192:385-397, 1995
2. RENNKE HG: How does glomerular epithelial cell injury contribute to progressive glomerular damage? Kidney Int 45(Suppl 45):S58-S63, 1994
3. KRETZLER M, KOEPPEN-HAGEMAN I, KRIZ W: Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomized-desoxycorticosterone hypertensive rat. Virchows Arch 425:181-193, 1994
4. KRIZ W: Progressive renal failure-inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 11:1738-1742, 1996
5. STRIKER LJ, DOI T, ELLIOT S, STRIKER GE: The contribution of glomerular cells to progressive glomerulosclerosis. Semin Nephrol 9:318-328, 1989
6. FLOEGE J, ENG E, LINDNER V, ALPERS CE, YOUNG BA, REIDY MA, JOHNSON RJ: Rat glomerular mesangial cells synthesize basic fibroblast growth factor. J Clin Invest 90:2362-2369, 1992
7. SOROKIN L, EKBLOM P: Development of tubular and glomerular cells of the kidney. Kidney Int 41:657-664, 1992
8. NAGATA M, YAMAGUCHI Y, ITO K: Loss of mitotic activity and the expression of vimentin in glomerular epithelial cells of developing human kidneys. Anat Embryol 187:275-279, 1993
9. NAGATA M, YAMAGUCHI Y, KOMATSU Y, ITO K: Mitosis and the presence of binucleate cells among glomerular podocytes in diseased human kidneys. Nephron 70:68-71, 1995
10. FLOEGE J, JOHNSON RJ, ALPERS CE, FATEMI-NAINIE S, RICHARDSON CA, GORDON K, COUSER WG: Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor β-chain. Am J Pathol 142:637-650, 1993
11. KRIZ W, HAHNEL B, ROSENER S, ELGER M: Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis. Kidney Int 48:1435-1450, 1995
12. FLOEGE J, KRIZ W, SCHULZE M, SUSANI M, KERJASCHKI D, MOONEY A, COUSER WG, KOCH KM: Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephrology. J Clin Invest 96:2809-2819, 1996
13. NORBURY C, NURSE P: Animal cell cycles and their control. Annu Rev Biochem 61:441-471, 1992
14. SHERR CJ: Mammalian G1 cyclins. Cell 73:1059-1065, 1993
15. MORGAN DO: Principles of CDK regulation. Nature 374:131-134, 1995
16. COLEMAN TR, DUNPHY WG: Cdc2 regulatory factors. Curr Opin Cell Biol 6:877-882, 1994
17. SHANKLAND SJ, HUGO C, COATS SR, NANGAKU M, PICHLER RH, GORDON KL, PIPPIN J, ROBERTS JM, COUSER WG, JOHNSON RJ: Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50:1230-1239, 1996
18. BAKER PJ, OCHI RF, SCHULZE M, JOHNSON RJ, CAMPBELL C, COUSER WG: Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am J Pathol 135:185-194, 1989
19. SALANT DJ, DARBY C, COUSER WG: Experimental membranous glomerulonephritis in rats. J Clin Invest 66:71-81, 1980
20. BRADLEY GM, BENSEN ES: Clinical Diagnosis by Laboratory Methods (15 ed), edited by DAVIDSON IHJ, New York, WB Saunders, 1974
21. FLOEGE J, ALPERS CE, SAGE EH, PRITZL P, GORDON K, JOHNSON RJ, COUSER WG: Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Lab Invest 67:486-497, 1992
22. SCHULZE M, PRUNCHO CJ, BURNS M, BAKER PJ, JOHNSON RJ, COUSER WG: Glomerular C3c localization indicates ongoing immune deposit formation and complement activation in experimental glomerulonephritis. Am J Pathol 142:179-187, 1993
23. SCHULZE M, BAKER PJ, PERKINSON DT, JOHNSON RJ, OCHI RF, STAHL RAF, COUSER WG: Increased urinary excretion of C5b-9 distinguishes passsive Heymann nephritis in the rat. Kidney Int 35:60-68, 1989
24. BAKER AJ, MOONEY A, HUGHES J, LOMBARDI D, JOHNSON RJ, SAVILL J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimenta mesangial proliferative nephritis. J Clin Invest 94:21115-2116, 1994
25. JOHNSON RJ: The glomerular response to injury: Progression or resolution. Kidney Int 45:1769-1782, 1993
26. COUSER WG: Mediation of immune glomerular injury. J Am Soc Nephrol 1:13-29, 1990
27. COUSER WG, SCHULZE M, PRUCHNO CJ: Role of C5b-9 in experimental membranous nephropathy. Nephrol Dial Transplant 1(Suppl):25-31, 1992
28. PINES J: Cyclins and cyclin-dependent kinases: A biochemical view. Biochem J 308:697-711, 1995
29. BALDIN V, LUKAS J, MARCOTE MJ, PAGANO M, DRAETTA G: Cyclin D1 is a protein required for cell cycle progression in G1. Genes Dev 7:812-821, 1993
30. OHTSUBO M, THEODORAS AM, SCHUMACHER J, ROBERTS JM, PAGANO M: Human cyclin E, a nuclear protein essentail for the G1-to-S phase transition. Molec Cell Biol 15:2612-2624, 1995
31. PAGANO M, PEPPERKOK R, VERDE F, ANSORGE W, DRAETTA G: Cyclin A is required at two points in the human cell cycle. EMBO J 11:961-971, 1992
32. SHERR CJ, ROBERTS JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163, 1995
33. EL-DEIRY WS, TOKINO T, VELCULESCU VE, LEVY DB, PARSONS R, TRENT JM, LIN D, MERCER WE, KINZLER KW, VOGELSTEIN B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993
34. HARPER JW, ADAMI GR, WEI N, KEYOMARSI K, ELLEDGE J: The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816, 1993
35. NODA A, NING Y, VENABLE SF, PEREIRA-SMITHS OM, SMITH JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using expression vectors. Exp Cell Res 211:90-98, 1994
36. TOYOSHIMA H, HUNTER T: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74, 1994
37. Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78:59, 1994
38. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22, 1994
39. HARPER JW, ELLEDGE SJ, KEYOMARSI K, DYNLACHT B, TSAI L, ZHANG P, DOBROWOLSKI S, BAI C, CONNELL-CROWLEY L, SWINDELL E, FOX MP, WEI N: Inhibition of cyclin dependent kinases by p21. Mol Biol Cell 6:387-400, 1995
40. COATS S, FLANAGAN WM, NOURSE J, ROBERTS JM: Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272:877-880, 1996
41. CROIX BRAD ST, FLORENS VA, RAK JW, FLANAGAN M, BHATTACHARYA N, SLINGERLAND JM, KERBEL RS: Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nature Med 2:1204-1210, 1996
42. ELBENDARY A, BERCHUCK A, DAVIS P, HAVRILESKY L, BAST RC, IGLEHART D, MARKS JR: Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Diff 5:1301-1307, 1994
43. SHANKLAND SJ, PIPPIN J, PICHLER RH, GORDON KL, FRIEDMAN S, GOLD LI, JOHNSON RJ, COUSER WG: Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathy. Kidney Int 50:116-124, 1996
44. MORRISSEY JJ, ISHIDOYA S, MCCRACKEN R, KLAHR S: The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis. Kidney Int 49(Suppl 54):S83-S87, 1996
45. YAMAMOTO T, WISON CB: Complement dependence of antibody-induced mesangial cell injury in the rat. J Immunol 138:3758-3765, 1987
46. NANGAKU M, PIPPIN J, ALPERS CE, SHANKLAND SJ, JOHNSON RJ, COUSER WG: Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9. Kidney Int (In press)
47. BRANDT J, PIPPIN J, SCHULZE M, HANSCH GM, ALPERS CE, JOHNSON RJ, GORDON K, COUSER WG: Role of complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int 49:335-343, 1996
48. CYBULSKY AV, RENNKE HG, FEINTZEIG ID, SALANT DJ: Complement-induced glomerular epithelial cell injury. Role of the membrane attack complex in rat membranous nephropathy. J Clin Invest 77: 1096-1107, 1986